sur AI/ML Innovations Inc. (isin : CA00143Y1034)
AI/ML Innovations Expands Board, Nominates New Director
AI/ML Innovations Inc. has announced significant updates leading up to its annual and special meeting on February 21, 2025. The company plans to increase its board seats from three to four, introducing an independent director.
Dr. Drew Dundas has been nominated to join the board, bringing over 20 years of expertise in technology and research. Currently the Chief Technology Officer at Earlens Corporation, Dr. Dundas has a history of leadership in audiology and healthcare technology.
Mark Orsmond, AIML's Executive Chairman, expressed enthusiasm for Dr. Dundas's nomination, highlighting the impact his experience could have on the company's AI-driven healthcare solutions.
Further details about the meeting can be found in the company's management information circular dated January 9, 2025.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de AI/ML Innovations Inc.